Advanced Therapies (AT) include Cell Therapy, Gene Therapy and Tissue Engineering, and constitute the forefront in current medicine. There are already 8 AT products on the market, and Spain occupies a prominent place in conducting clinical trials in this area.

The fundamental objective of this Group coordinated by VIVEbiotech is to ensure the active participation of biotechnology companies in decision-making regarding the development of these therapies, and their final application in the people who require them.